Skip to the content
logo mainlogo darklogo light
logo main
logo mainlogo darklogo light
HomePortfolio

CRO

Consultation
Workflow
Tailor-Made Protocol
Workflow
s
State-of-the-art experimentation
Workflow
s
Reporting
Workflow
s
3D cell culture
In vitro / Ex vivo Systems
s
2D cell culture
In vitro / Ex vivo Systems
s
Sample Collection
PK/PD studies
s
Biochemical-hematological analysis
PK/PD studies
s
Shipment to Clients
PK/PD studies
Stains
Histology
s
Immunohistochemistry
Histology
s
Pathology evaluation
Histology

Humanized

d
TNF
Humanized Targets
v
TNF Receptor-1
Humanized Targets
m
IL-17
Humanized Targets
d
IL-23A
Humanized Targets
v
IL-12B
Humanized Targets
m
RANKL
Humanized Targets

Subscribe for updates

    Company

    • Our Team
    • Our Story
    • Careers

    Athens, Greece

    • 34 Al. Fleming Street, Vari, 16672
    • +30 210 9655366

    Useful Links

    • Privacy Policy
    • Cookies Policy
    • Contact Us
    •  
    • Logo

    © 2023 Biomedcode , All Rights Reserved

    Back to top Drag
    w
    • CRO
      Preclinical Services
      • Our Pipeline
      • In vivo Models
      • In vitro / Ex vivo Models
      • PK/PD studies
      • Histology
      • Analysis Methods
    • Humanized
      Targets
      • TNF
      • TNF Receptor-1
      • IL-17
      • IL-23A
      • IL-12B
      • RANKL
    • Therapeutic
      Areas
      • Acute Inflammation
      • Arthritis
      • Cancer
      • Fibrosis
      • Infectious Diseases
      • Inflammatory Bowel Disease
      • Lupus
      • Multiple Sclerosis
      • Osteoporosis
      • Skin Inflammation
      • Spondyloarthritis
    • Research and
      Development
      • R&D Activities
      • Research Projects
      • Publications
    • About Us
      • Our Story
      • Our People
      • Join us!